The terminal reaction of cholesterol synthesis, the conversion of 7-dehydrocholesterol to cholesterol, is catalyzed by the NADPH -requiring enzyme, 7-dehydrocholesterol reductase (encoded by the DHCR7 gene)
These GLP-1 drugs really just highlight how, if you can just override your biology, how much of an effect you get, Dr
Laviano A, Molfino A, Lacaria MT, Canelli A, De Leo S, Preziosa I, Rossi Fanelli F
Methods 25:402408
Peripherally, they improve blood sugar control, enhance insulin secretion, and delay gastric emptying
The rationale for a GLP-1 drug is its powerful body-wide and brain anti-inflammatory properties, says Eric Topol, a cardiologist and the director of the La Jolla, California-based Scripps Research Translational Institute, which is sponsoring the trial